Literature DB >> 15735459

Prevalence and persistence of nonnucleoside reverse transcriptase inhibitor mutations in the female genital tract.

Michael Newstein, Phyllis Losikoff, Angela Caliendo, Jessica Ingersoll, Jaclynn Kurpewski, Dawn Hanley, Joselyn Cerezo, Bharat Ramratnam, Susan Cu-Uvin.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 15735459

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  5 in total

1.  Prevalence of drug-resistance mutations and non-subtype B strains among HIV-infected infants from New York State.

Authors:  Marine Karchava; Wendy Pulver; Lou Smith; Sean Philpott; Timothy J Sullivan; Judith Wethers; Monica M Parker
Journal:  J Acquir Immune Defic Syndr       Date:  2006-08-15       Impact factor: 3.731

Review 2.  Clinical parameters essential to methodology and interpretation of mucosal responses.

Authors:  Brenna L Anderson; Susan Cu-Uvin
Journal:  Am J Reprod Immunol       Date:  2011-01-12       Impact factor: 3.886

3.  Perinatal acquisition of drug-resistant HIV-1 infection: mechanisms and long-term outcome.

Authors:  Constance Delaugerre; Marie-Laure Chaix; Stephane Blanche; Josiane Warszawski; Dorine Cornet; Catherine Dollfus; Veronique Schneider; Marianne Burgard; Albert Faye; Laurent Mandelbrot; Roland Tubiana; Christine Rouzioux
Journal:  Retrovirology       Date:  2009-09-19       Impact factor: 4.602

4.  Genital Shedding of Resistant Human Immunodeficiency Virus-1 Among Women Diagnosed With Treatment Failure by Clinical and Immunologic Monitoring.

Authors:  Susan M Graham; Vrasha Chohan; Keshet Ronen; Ruth W Deya; Linnet N Masese; Kishor N Mandaliya; Norbert M Peshu; Dara A Lehman; R Scott McClelland; Julie Overbaugh
Journal:  Open Forum Infect Dis       Date:  2016-02-02       Impact factor: 3.835

Review 5.  Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here?

Authors:  Myron S Cohen; M Kumi Smith; Kathryn E Muessig; Timothy B Hallett; Kimberly A Powers; Angela D Kashuba
Journal:  Lancet       Date:  2013-10-23       Impact factor: 79.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.